Inventor
LUGOVSKOY ALEXEY A
US25 patents
⚠️ This page may combine multiple inventors who share the name “LUGOVSKOY ALEXEY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MORPHIC THERAPEUTIC INC
10 patentsUS11827621B2Nov 28, 2023
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC5 citations85
US11795167B2Oct 24, 2023
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC5 citations85
US11046685B2Jun 29, 2021
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US11046669B2Jun 29, 2021
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US11040955B2Jun 22, 2021
Inhibitors of (alpha-v)(beta-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US10759756B2Sep 1, 2020
Antagonists of human integrin α4β7
MORPHIC THERAPEUTIC INC7 citations83
US12415796B2Sep 16, 2025
Inhibitors of (αv)(β6) integrin
MORPHIC THERAPEUTIC INC2 citations74
US12145935B2Nov 19, 2024
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC4 citations74
US11174228B2Nov 16, 2021
Antagonists of human integrin (α4)(β7)
MORPHIC THERAPEUTIC INC1 citations72
US12221416B2Feb 11, 2025
Antagonists of human integrin α4β7
MORPHIC THERAPEUTIC INC0 citations61
BIOGEN MA INC
4 patentsUS9790229B2Oct 17, 2017
Bruton's tyrosine kinase inhibitors
BIOGEN MA INC11 citations83
US10335485B2Jul 2, 2019
Anti-VLA-4 antibodies
BIOGEN MA INC7 citations81
US11571477B2Feb 7, 2023
Anti-VLA-4 antibodies
BIOGEN MA INC2 citations70
US11083791B2Aug 10, 2021
Anti-VLA-4 antibodies
BIOGEN MA INC4 citations70
MERRIMACK PHARMACEUTICALS INC
4 patentsUS9226964B2Jan 5, 2016
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC9 citations82
US10072299B2Sep 11, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49
US9902999B2Feb 27, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49
US9885087B2Feb 6, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49